Glasser SP - Search Results

1

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.

DeMots H, Glasser SP. DeMots H, et al. Among authors: glasser sp. J Am Coll Cardiol. 1989 Mar 15;13(4):786-95. doi: 10.1016/0735-1097(89)90216-7. J Am Coll Cardiol. 1989. PMID: 2494240 Free article. Clinical Trial.

2

Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.

Glasser SP, West TW. Glasser SP, et al. Am J Cardiol. 1988 Sep 15;62(9):518-22. doi: 10.1016/0002-9149(88)90647-9. Am J Cardiol. 1988. PMID: 2970788 Clinical Trial.

3

Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.

Glasser SP, Bittar N, Labreche DG, Singh B, Katz R, Schulman P. Glasser SP, et al. Am J Cardiol. 1994 Jun 15;73(16):1165-8. doi: 10.1016/0002-9149(94)90175-9. Am J Cardiol. 1994. PMID: 7911271 Clinical Trial.

4

Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).

Borzak S, Fenton T, Glasser SP, Shook TL, MacCallum G, Young PM, Stone PH. Borzak S, et al. Among authors: glasser sp. J Am Coll Cardiol. 1993 Jun;21(7):1605-11. doi: 10.1016/0735-1097(93)90375-b. J Am Coll Cardiol. 1993. PMID: 8496526 Free article. Clinical Trial.

5

Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.

Thadani U, Glasser S, Bittar N, Beach CL. Thadani U, et al. Am J Cardiol. 1994 Jul 1;74(1):9-17. doi: 10.1016/0002-9149(94)90483-9. Am J Cardiol. 1994. PMID: 8017316 Clinical Trial.

6

Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris.

Glasser SP, Friedman R, Talibi T, Smith LK, Weir EK. Glasser SP, et al. Am J Cardiol. 1994 Feb 1;73(4):213-8. doi: 10.1016/0002-9149(94)90221-6. Am J Cardiol. 1994. PMID: 8296748 Clinical Trial.

7

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P. Thadani U, et al. J Am Coll Cardiol. 2002 Dec 4;40(11):2006-12. doi: 10.1016/s0735-1097(02)02563-9. J Am Coll Cardiol. 2002. PMID: 12475462 Free article. Clinical Trial.

8

Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.

Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD. Frishman WH, et al. Am J Cardiol. 1999 Feb 15;83(4):507-14. doi: 10.1016/s0002-9149(98)00904-7. Am J Cardiol. 1999. PMID: 10073852 Clinical Trial.

9

Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.

Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, Ibrahim R, Watts LE, Garutti RJ, Ferraresi R, Casareto R. Chrysant SG, et al. Among authors: glasser sp. Am J Cardiol. 1993 Dec 1;72(17):1249-56. doi: 10.1016/0002-9149(93)90292-k. Am J Cardiol. 1993. PMID: 8256699 Clinical Trial.

10

Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.

Glasser SP. Glasser SP. Am J Cardiol. 1997 Dec 15;80(12):1546-50. doi: 10.1016/s0002-9149(97)00802-3. Am J Cardiol. 1997. PMID: 9416933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page